I went through a similar fiasco with Trimeris, Inc

I went through a similar fiasco with Trimeris, Inc. back in 1998. They were developing a new class of HIV treatment, T-20 (pentafuside), known as a fusion inhibitor. Using a viral sequence from the actual HIV virus, researchers developed T-20 (a 36-amino acid portion of gp41) to inhibit the virus from binding to, entering, and infecting healthy cells. T-20 also blocked infected cells from fusing with uninfected cells. T-20 showed a high degree of antiviral activity, no toxicity, and a low chance of developing cross resistance.

That was the first time I was made aware of fusion inhibitors GP120 and GP41. In 2021 I fell off the floor and hit the ceiling when they introduced the mRNA vaccine with GP120 glycoprotein and then dropped from the ceiling and hit the floor when they announced the Corona virus vaccine with GP41. Ouch ! Oi Gavalt! Flying AIDS what could possibly go wrong here?

The good news is this if you search using the terms < Virus / Fungal / Bacteria - Name> plus <molecular docking> then < Mpro or Replication inhibitor> You can then find a organic molecule that will inhibit the " Disease Dejour " the Pfizer 5 rule is simply the rules they use when synthesizing a protein that chemically mimics an organic molecule. Why? You cannot patent an existing molecule, however you can patent a new synthesized protein.

I hanging on to my tiny pile of shares and what the heck buy a couple of million more.
Trimeris went to 75.00 when they were bought out. I only owned 10,000 shares so that worked out okay. It was one heck of a roller coaster ride. I love you guys and gals for hanging in there so let's maintain the vision and call every important person we know. I'm shameless about changing the future of mankind and making the world a better place. The only thing that beats a failure is a try!